1. Home
  2. NBN vs ODTX Comparison

NBN vs ODTX Comparison

Compare NBN & ODTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Northeast Bank

NBN

Northeast Bank

N/A

Current Price

$125.01

Market Cap

1.1B

Sector

Finance

ML Signal

N/A

Logo Odyssey Therapeutics Inc. Common Stock

ODTX

Odyssey Therapeutics Inc. Common Stock

N/A

Current Price

$19.17

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NBN
ODTX
Founded
1872
2021
Country
United States
United States
Employees
225
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.3B
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
NBN
ODTX
Price
$125.01
$19.17
Analyst Decision
Hold
Strong Buy
Analyst Count
2
8
Target Price
★ $145.50
$35.33
AVG Volume (30 Days)
93.9K
★ 228.1K
Earning Date
10-26-2026
11-12-2026
Dividend Yield
★ 0.03%
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$11.29
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$80.75
$15.10
52 Week High
$142.31
$29.05

Technical Indicators

Market Signals
Indicator
NBN
ODTX
Relative Strength Index (RSI) 42.43 46.77
Support Level $121.69 $15.73
Resistance Level $126.68 $19.60
Average True Range (ATR) 3.75 1.35
MACD 0.25 0.31
Stochastic Oscillator 17.32 65.85

Price Performance

Historical Comparison
NBN
ODTX

About NBN Northeast Bank

Northeast Bank provides banking and financial services to individual and corporate customers in the United States. The bank conducts its loan-related activities through two primary channels: the National Lending Division and the Small Business Division. Its loan portfolio comprises residential mortgage loans; multi-family and other commercial real estate loans; commercial and industrial loans; consumer loans; and small business administration loans, among others. Additionally, the bank provides telephone banking, online banking, mobile banking, and remote deposit capture services, and other banking products and services. The majority of its revenue is derived in the form of interest and dividends.

About ODTX Odyssey Therapeutics Inc. Common Stock

Odyssey Therapeutics Inc is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases. The Company is developing medicines that are designed to precisely target disease pathology with an initial emphasis on the innate immune system. Its programs include OD-07656, a small molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, a small molecule scaffolding inhibitor of interleukin-1 receptor-associated kinase 4, or IRAK4, and OD-00910, an agonistic protein therapeutic targeting tumor necrosis factor receptor 2, or TNFR2, built from camelid heavy chain variable regions, or VHH, domains.

Share on Social Networks: